No Data
No Data
Pfizer to Advance Development of Modified-Release Formulation of Danuglipron
Pfizer (PFE) said Thursday it will conduct dose optimization studies of danuglipron in the second half of the year after selecting a once-daily, modified-release formulation of the drug candidate
Morgan Stanley Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $29
Morgan Stanley analyst Terence Flynn maintains $Pfizer(PFE.US)$ with a hold rating, and maintains the target price at $29.According to TipRanks data, the analyst has a success rate of 64.8% and a
Trending Tickers: Tesla, Nvidia, Pfizer and Superdry
This Weight Loss Stock Is the Best Alternative to Eli Lilly, Novo - SA Sentiment
Jefferies Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $32
Jefferies analyst Akash Tewari maintains $Pfizer(PFE.US)$ with a buy rating, and maintains the target price at $32.According to TipRanks data, the analyst has a success rate of 58.5% and a total
Pfizer Options Spot-On: On July 11th, 206.89K Contracts Were Traded, With 2.84 Million Open Interest
On July 11th ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 206.89K options for the day, of which put options accounted for 31.5% of the total transactions, and call
loading...
No Data